1. Home
  2. NHP vs COLL Comparison

NHP vs COLL Comparison

Compare NHP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Healthcare Properties Inc. Class A Common Stock

NHP

National Healthcare Properties Inc. Class A Common Stock

N/A

Current Price

$16.00

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$22.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHP
COLL
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
NHP
COLL
Price
$16.00
$22.60
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$51.40
AVG Volume (30 Days)
403.6K
806.6K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
65.09
N/A
EPS
N/A
N/A
Revenue
$342,279,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.62
52 Week Low
$13.68
$21.65
52 Week High
$17.46
$50.79

Technical Indicators

Market Signals
Indicator
NHP
COLL
Relative Strength Index (RSI) 47.98 28.57
Support Level $15.75 N/A
Resistance Level $16.84 $35.33
Average True Range (ATR) 0.45 0.88
MACD -0.04 0.13
Stochastic Oscillator 40.32 26.24

Price Performance

Historical Comparison
NHP
COLL

About NHP National Healthcare Properties Inc. Class A Common Stock

National Healthcare Properties Inc is a publicly registered real estate investment trust. It is focused on acquiring, owning, and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. The company operates in two reportable business segments: SHOP and OMF. The SHOP segment consists of assisted living communities, memory care communities and independent living communities, which are focused on needs-based assisted living and memory care. The OMF segment consists of physicians' offices and examination rooms, hospitals, pharmacies, hospital ancillary service space and other outpatient services. The majority of revenue is derived from the SHOP segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: